Evidence map›Paper›PMID 28728169›Full record

ArticleInvestigative ophthalmology & visual science2017

Correlations Between Macular, Skin, and Serum Carotenoids.

Christopher D Conrady, James P Bell, Brian M Besch, Aruna Gorusupudi, Kelliann Farnsworth, Igor Ermakov, Mohsen Sharifzadeh, Maia Ermakova, Werner Gellermann, Paul S Bernstein

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04676126 (Augmented Macular Pigment Supplement and Pericentral Visual Function), which is not on this map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04676126 phase4withdrawnnot on this mapstarted 2021, after this paper: background citation

Augmented Macular Pigment Supplement and Pericentral Visual Function: a Randomized Controlled Trial

TypeinterventionalSponsorUniversity of the Incarnate WordRan2021 to 2022Enrolled0ConditionsGlaucoma, Glaucoma Eye, Glaucoma, Open-AngleArmsLumega-Z, Dorzolamide Hcl 2% Oph Soln, Placebo
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Comparing 2-dimensional macular pigment optical density with objective and subjective perimetry and visual acuity in age-related macular degeneration.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christopher D ConradyDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, Salt Lake City, Utah, United States.
James P BellDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, Salt Lake City, Utah, United States.
Brian M BeschDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, Salt Lake City, Utah, United States.
Aruna GorusupudiDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, Salt Lake City, Utah, United States.
Kelliann FarnsworthDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, Salt Lake City, Utah, United States.
Igor ErmakovImage Technologies Corporation, Salt Lake City, Utah, United States.
Mohsen SharifzadehImage Technologies Corporation, Salt Lake City, Utah, United States.
Maia ErmakovaImage Technologies Corporation, Salt Lake City, Utah, United States.
Werner GellermannDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, Salt Lake City, Utah, United States 2Image Technologies Corporation, Salt Lake City, Utah, United States.
Paul S BernsteinDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, Salt Lake City, Utah, United States.

Funding

University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Bryan William Jones · 2005 to 2026
$14.6M
Biochemistry and Pharmacology of the Macular CarotenoidsR01EY011600 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI BERNSTEIN, PAUL STEVEN · 2004 to 2025
$7.7M
BIOCHEMISTRY AND PHARMACOLOGY OF THE MACULAR CAROTENOIDSR29EY011600 · NEI · UNIVERSITY OF UTAH · PI BERNSTEIN, PAUL STEVEN · 1997 to 2001
$209k
NEI NIH HHS P30 EY014800NEI NIH HHS R01 EY011600NEI NIH HHS R29 EY011600
6 · The paper itself

Abstract

Purpose: Ocular and systemic measurement and imaging of the macular carotenoids lutein and zeaxanthin have been employed extensively as potential biomarkers of AMD risk. In this study, we systematically compare dual wavelength retinal autofluorescence imaging (AFI) of macular pigment with skin resonance Raman spectroscopy (RRS) and serum carotenoid levels in a clinic-based population. Methods: Eighty-eight patients were recruited from retina and general ophthalmology practices from a tertiary referral center and excluded only if they did not have all three modalities tested, had a diagnosis of macular telangiectasia (MacTel) or Stargardt disease, or had poor AFI image quality. Skin, macular, and serum carotenoid levels were measured by RRS, AFI, and HPLC, respectively. Results: Skin RRS measurements and serum zeaxanthin concentrations correlated most strongly with AFI macular pigment volume under the curve (MPVUC) measurements up to 9° eccentricity relative to MPVUC or rotationally averaged macular pigment optical density (MPOD) measurements at smaller eccentricities. These measurements were reproducible and not significantly affected by cataracts. We also found that these techniques could readily identify subjects taking oral carotenoid-containing supplements. Conclusions: Larger macular pigment volume AFI and skin RRS measurements are noninvasive, objective, and reliable methods to assess ocular and systemic carotenoid levels. They are an attractive alternative to psychophysical and optical methods that measure MPOD at a limited number of eccentricities. Consequently, skin RRS and MPVUC at 9° are both reasonable biomarkers of macular carotenoid status that could be readily adapted to research and clinical settings.

Indexed as

AdolescentAdultAgedAged, 80 and overCarotenoidsChromatography, High Pressure LiquidDietDietary SupplementsFemaleHumansLuteinMacula LuteaMacular PigmentMaleMiddle AgedOptical ImagingCarotenoidsLuteinMacular PigmentZeaxanthins

Identifiers

PMID28728169
PMCPMC5520678
OpenAlexW2738225955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.